Cargando…

Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) emerged in late 2019 and resulted in a devastating pandemic. Although the first approved vaccines were already administered by the end of 2020, worldwide vaccine availability is still limited. Mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rand, Ulfert, Kupke, Sascha Young, Shkarlet, Hanna, Hein, Marc Dominique, Hirsch, Tatjana, Marichal-Gallardo, Pavel, Cicin-Sain, Luka, Reichl, Udo, Bruder, Dunja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303422/ https://www.ncbi.nlm.nih.gov/pubmed/34359926 http://dx.doi.org/10.3390/cells10071756

Ejemplares similares

Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In Vitro
por: Pelz, Lars, et al.
Publicado: (2023)

Generation of “OP7 chimera” defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice
por: Dogra, Tanya, et al.
Publicado: (2023)

OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential
por: Hein, Marc D., et al.
Publicado: (2020)

Foscarnet-Type Inorganic-Organic Hybrid Nanoparticles for Effective Antiviral Therapy
por: Khorenko, Mikhail, et al.
Publicado: (2022)

Multiscale model of defective interfering particle replication for influenza A virus infection in animal cell culture
por: Rüdiger, Daniel, et al.
Publicado: (2021)

Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles
por: Hein, Marc D., et al.
Publicado: (2021)

A Novel Triple-Fluorescent HCMV Strain Reveals Gene Expression Dynamics and Anti-Herpesviral Drug Mechanisms
por: Rand, Ulfert, et al.
Publicado: (2021)

Cell culture–based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system
por: Hein, Marc D., et al.
Publicado: (2021)

Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy
por: Pelz, Lars, et al.
Publicado: (2021)

A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome
por: Kupke, Sascha Young, et al.
Publicado: (2019)

Fibroblasts are a site of murine cytomegalovirus lytic replication and Stat1-dependent latent persistence in vivo
por: Sitnik, Katarzyna M., et al.
Publicado: (2023)

The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting
por: Zimmer, Matthias M., et al.
Publicado: (2021)

Single-Cell Analysis Uncovers a Vast Diversity in Intracellular Viral Defective Interfering RNA Content Affecting the Large Cell-to-Cell Heterogeneity in Influenza A Virus Replication
por: Kupke, Sascha Young, et al.
Publicado: (2020)

Persicamidines—Unprecedented Sesquarterpenoids with Potent Antiviral Bioactivity against Coronaviruses
por: Keller, Lena, et al.
Publicado: (2023)

Cell culture-based production of defective interfering particles for influenza antiviral therapy
por: Wasik, Milena A., et al.
Publicado: (2017)

Multiscale modeling of influenza A virus replication in cell cultures predicts infection dynamics for highly different infection conditions
por: Rüdiger, Daniel, et al.
Publicado: (2019)

Single-cell transcriptional profiling of splenic fibroblasts reveals subset-specific innate immune signatures in homeostasis and during viral infection
por: Pezoldt, Joern, et al.
Publicado: (2021)

Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses
por: Jiang, Ben, et al.
Publicado: (2023)

Synthetic rewiring and boosting type I interferon responses for visualization and counteracting viral infections
por: Gödecke, Natascha, et al.
Publicado: (2020)

Influenza virus intracellular replication dynamics, release kinetics, and particle morphology during propagation in MDCK cells
por: Frensing, Timo, et al.
Publicado: (2016)

Single-cell analysis and stochastic modelling unveil large cell-to-cell variability in influenza A virus infection
por: Heldt, Frank S., et al.
Publicado: (2015)

Antiviral effects of natural small molecules on aquatic rhabdovirus by interfering with early viral replication
por: Zhou, Yan, et al.
Publicado: (2022)

TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection
por: Metzdorf, Kristin, et al.
Publicado: (2023)

Production of retroviral vectors in continuous high cell density culture
por: Hein, Marc D., et al.
Publicado: (2023)

Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge
por: Zheng, Xiaoyan, et al.
Publicado: (2019)

A system for production of defective interfering particles in the absence of infectious influenza A virus
por: Bdeir, Najat, et al.
Publicado: (2019)

Human monocyte-derived macrophages inhibit HCMV spread independent of classical antiviral cytokines
por: Becker, Jennifer, et al.
Publicado: (2018)

Vaccine Vectors Harnessing the Power of Cytomegaloviruses
por: Ynga-Durand, Mario Alberto, et al.
Publicado: (2019)

Interfering antiviral immunity: application, subversion, hope?
por: Manjunath, N., et al.
Publicado: (2006)

Design of Small Interfering RNAs for Antiviral Applications
por: Rothe, Diana, et al.
Publicado: (2010)

A Replicating Cytomegalovirus-Based Vaccine Encoding a Single Ebola Virus Nucleoprotein CTL Epitope Confers Protection against Ebola Virus
por: Tsuda, Yoshimi, et al.
Publicado: (2011)

A new reporter mouse cytomegalovirus reveals maintained immediate-early gene expression but poor virus replication in cycling liver sinusoidal endothelial cells
por: Dag, Franziska, et al.
Publicado: (2013)

Reversible Silencing of Cytomegalovirus Genomes by Type I Interferon Governs Virus Latency
por: Dağ, Franziska, et al.
Publicado: (2014)

Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein
por: Ruhnau, Johannes, et al.
Publicado: (2021)

Continuous Influenza Virus Production in Cell Culture Shows a Periodic Accumulation of Defective Interfering Particles
por: Frensing, Timo, et al.
Publicado: (2013)

Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies
por: Pommerenke, Claudia, et al.
Publicado: (2021)

Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells
por: Plumlee, Courtney R, et al.
Publicado: (2005)

FUS/TLS Suppresses Enterovirus Replication and Promotes Antiviral Innate Immune Responses
por: Xue, Yuan Chao, et al.
Publicado: (2021)

Pigeon MDA5 inhibits viral replication by triggering antiviral innate immunity
por: Shao, Qi, et al.
Publicado: (2023)

Integrated coastal and ocean management : concepts and practices
por: Cicin-Sain, Biliana
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_29nfq3v9lcdjiqfnl3krrt9l7o